Degatide 120 Injection
Marketer
Cipla Ltd
Salt Composition
Degarelix (120mg)
Overview Degatide 120 Injection
Degatride 120 Injection treats advanced prostate cancer by reducing the body's testosterone production, thereby inhibiting cancer cell proliferation. Administered subcutaneously by a healthcare professional only, self-injection is strictly prohibited due to the risk of accidental intravenous administration. Dosage and frequency are determined by your physician based on individual needs and symptom management. Continue treatment as prescribed. Common side effects include injection site reactions (pain, swelling, redness), weight gain, hot flushes, elevated liver enzymes, and reduced libido. Report any concerning or persistent side effects to your doctor; management strategies may be available. Avoid driving or operating machinery if experiencing dizziness or sleep disturbances. Prior to treatment, inform your doctor of any pre-existing conditions, such as heart disease, diabetes, or liver disease, and all other medications being taken, as interactions may affect efficacy. Disclose pregnancy or breastfeeding status. Your doctor may monitor prostate-specific antigen (PSA) levels to assess treatment effectiveness.
Primary Ingredients of Degatide 120 Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Degatide 120 Injection
Malignancy of the prostate gland
Major Benefits of Degatide 120 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Degatide 120 Injection:
- Injection site reactions (pain, swelling, redness)
- Weight gain
- Hot flashes
- Increased liver enzymes
- Low sexual desire
- Erectile dysfunction
How to use Degatide 120 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Degatide 120 Injection works:
Degatide 120 Injection reduces endogenous testosterone production. This can inhibit the proliferation and metastasis of testosterone-dependent prostate cancer cells.
SAFETY ADVICE
AlcoholCAUTION
Use of Degatide 120 Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Degatide 120 Injection to pregnant individuals poses a considerable risk. Pregnant women should consult their physician before use, as research in animals and humans indicates substantial adverse effects on fetal development.
Breast feedingCONSULT YOUR DOCTOR
Data on Degatide 120 Injection use while breastfeeding is absent. Seek your physician's advice.
DrivingUNSAFE
Administering Degatide 120 Injection can lead to drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data on Degatide 120 Injection's use in patients with renal impairment is scarce. Physician consultation is recommended. Patients with severe kidney disease should receive Degatide 120 Injection with caution.
LiverCAUTION
Exercise caution when administering Degatide 120 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Dosage alterations are not typically required for patients exhibiting mild to moderate liver dysfunction. Routine monitoring of testosterone concentrations is recommended.
What if you forget to take Degatide 120 Injection :
Should you forget a scheduled Degatide 120 Injection, seek medical advice.
Facts to Know About Degatide 120 Injection
| Label | Value |
|---|---|
| Chemical Type | Peptide chains |
| Developing Habits | No. |
| Type of Therapy | Endocrine Signals |
| Actions | GnRH receptor blockers |
3,018 People bought this recently